BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 20506108)

  • 1. Protein phosphorylation and kinome profiling reveal altered regulation of multiple signaling pathways in B lymphocytes from patients with systemic lupus erythematosus.
    Taher TE; Parikh K; Flores-Borja F; Mletzko S; Isenberg DA; Peppelenbosch MP; Mageed RA
    Arthritis Rheum; 2010 Aug; 62(8):2412-23. PubMed ID: 20506108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased Lyn expression and translocation to lipid raft signaling domains in B lymphocytes from patients with systemic lupus erythematosus.
    Flores-Borja F; Kabouridis PS; Jury EC; Isenberg DA; Mageed RA
    Arthritis Rheum; 2005 Dec; 52(12):3955-65. PubMed ID: 16320343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
    Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral circulating activated b-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus.
    Dolff S; Wilde B; Patschan S; Dürig J; Specker C; Philipp T; Kribben A; Witzke O
    Scand J Immunol; 2007 Nov; 66(5):584-90. PubMed ID: 17868260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
    Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF
    Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.
    Papadimitraki ED; Choulaki C; Koutala E; Bertsias G; Tsatsanis C; Gergianaki I; Raptopoulou A; Kritikos HD; Mamalaki C; Sidiropoulos P; Boumpas DT
    Arthritis Rheum; 2006 Nov; 54(11):3601-11. PubMed ID: 17075805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Syk phosphorylation leads to overexpression of TRAF6 in peripheral B cells of patients with systemic lupus erythematosus.
    Iwata S; Yamaoka K; Niiro H; Jabbarzadeh-Tabrizi S; Wang SP; Kondo M; Yoshikawa M; Akashi K; Tanaka Y
    Lupus; 2015 Jun; 24(7):695-704. PubMed ID: 25432781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and occupancy of BAFF-R on B cells in systemic lupus erythematosus.
    Carter RH; Zhao H; Liu X; Pelletier M; Chatham W; Kimberly R; Zhou T
    Arthritis Rheum; 2005 Dec; 52(12):3943-54. PubMed ID: 16320342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation signal transduction by beta1 integrin in T cells from patients with systemic lupus erythematosus.
    Nakayamada S; Saito K; Nakano K; Tanaka Y
    Arthritis Rheum; 2007 May; 56(5):1559-68. PubMed ID: 17469136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events.
    Liossis SN; Kovacs B; Dennis G; Kammer GM; Tsokos GC
    J Clin Invest; 1996 Dec; 98(11):2549-57. PubMed ID: 8958217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus.
    Nambiar MP; Fisher CU; Warke VG; Krishnan S; Mitchell JP; Delaney N; Tsokos GC
    Arthritis Rheum; 2003 Jul; 48(7):1948-55. PubMed ID: 12847689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased ubiquitination and reduced expression of LCK in T lymphocytes from patients with systemic lupus erythematosus.
    Jury EC; Kabouridis PS; Abba A; Mageed RA; Isenberg DA
    Arthritis Rheum; 2003 May; 48(5):1343-54. PubMed ID: 12746907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell signaling abnormalities in systemic lupus erythematosus are associated with increased mutations/polymorphisms and splice variants of T cell receptor zeta chain messenger RNA.
    Nambiar MP; Enyedy EJ; Warke VG; Krishnan S; Dennis G; Wong HK; Kammer GM; Tsokos GC
    Arthritis Rheum; 2001 Jun; 44(6):1336-50. PubMed ID: 11407693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus.
    Lajaunias F; Ida A; Kikuchi S; Fossati-Jimack L; Martinez-Soria E; Moll T; Law CL; Izui S
    Arthritis Rheum; 2003 Jun; 48(6):1612-21. PubMed ID: 12794829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation.
    Garaud S; Le Dantec C; Jousse-Joulin S; Hanrotel-Saliou C; Saraux A; Mageed RA; Youinou P; Renaudineau Y
    J Immunol; 2009 May; 182(9):5623-32. PubMed ID: 19380809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of inducible costimulator in the exaggerated memory B cell and plasma cell generation in systemic lupus erythematosus.
    Hutloff A; Büchner K; Reiter K; Baelde HJ; Odendahl M; Jacobi A; Dörner T; Kroczek RA
    Arthritis Rheum; 2004 Oct; 50(10):3211-20. PubMed ID: 15476242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal telomerase activity and telomere length in T and B cells from patients with systemic lupus erythematosus.
    Kurosaka D; Yasuda J; Yoshida K; Yoneda A; Yasuda C; Kingetsu I; Toyokawa Y; Yokoyama T; Saito S; Yamada A
    J Rheumatol; 2006 Jun; 33(6):1102-7. PubMed ID: 16755657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
    Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
    Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Abnormal signaling activity of phosphatidylinositol 3-kinase pathway in peripheral blood T cells from patients with systemic lupus erythematosus].
    Liang LQ; Zhan ZP; Xu HS; Yang XY; Ye YJ; Lian F; Qiu Q
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2036-40. PubMed ID: 19080430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.